Intriguingly, the 4 SSAs that predictably would give rise to carcinomas of the CMS4 (further referred to as CMS4‐SSAs) showed high expression of a subset of genes present in the in vitro TGFβ response signature (Fig 4B). The gene discussed is TGFB1; the disease is carcinoma.